Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| ALLIANCE FIB | AFOP | 16.09% |
| A M R CP | AAMRQ | 9.04% |
| JAZZ PHARMAC | JAZZ | 5.30% |
| DIXIE GROUP | DXYN | 5.59% |
| SANTARUS INC | SNTS | 4.53% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
This prompted analysts to raise their estimates for both 2012 and 2013, sending the stock to a Zacks #1 Rank (Strong Buy).
Cyclical as She Goes
Timken manufactures bearings, alloy steel, and other related components. The company is very cyclical and highly dependent on the health of the overall economy.
So as you can imagine, shares have pulled back a bit recently along with the overall market. But so far Timken continues to deliver strong results. And if global growth concerns turn out to be overblown, this stock could soar.
First Quarter Results
Timken delivered strong results for the first quarter of 2012 on April 24. Earnings per share came in at $1.58, beating the Zacks Consensus Estimate by 32 cents. It was a stellar 40% increase over the same quarter in 2011. So how'd they get there?
First, revenues jumped 13% to $1.421 billion, a quarterly record. It was also ahead of the Zacks Consensus Estimate of $1.372 billion. The Process Industries and Steel segments remained particularly strong due in part to strong demand.
Secondly, margins expanded. Gross profit improved from 26.6% of net sales to 29.0%. And operating income expanded from 14.5% of net sales to 17.4% as the company leveraged its selling, general and administrative expenses.
Outlook
Following strong Q1 results, management provided encouraging guidance for the remainder of 2012. The company stated that it expects EPS between $5.40 and $5.70 on sales growth of 7-10%.
This prompted analysts to revise their estimates higher for both 2012 and 2013, sending the stock to a Zacks #1 Rank (Strong Buy).
The Zacks Consensus Estimate for 2012 is now $5.76, slightly above guidance. This corresponds with EPS growth of 26%. The 2012 consensus estimate is currently $6.38, representing 11% EPS growth.
As you can see in Timken's Price & Consensus chart, consensus estimates have been trending significantly higher over the last several months as the company has delivered 11 straight positive earnings surprises:
Dividend
On top of solid earnings growth, Timken pays a dividend that yields 1.9%. The company has raised it 4 times since early 2010, including a 15% increase earlier this year. But it did cut it in half during the Great Recession.
Valuation
The recent pullback in the stock market has led to some compelling valuations, as long as a recession isn't right around the corner.
Shares trade at just 7.9x 12-month forward earnings, a significant discount to the industry average of 10.5x and its 10-year historical median of 12.1x.
Its PEG ratio is only 0.6 based on a 5-year EPS growth rate of 13.6%.
The Bottom Line
With rising earnings estimates, strong growth projections, a solid 1.9% dividend yield and very attractive valuation, Timken offers investors a lot of upside potential...as long as the economy continues to at least slowly improve.
Todd Bunton is the Growth & Income Stock Strategist for Zacks Investment Research and Co-Editor of the Reitmeister Value Investor.
Read the full Snapshot Report on TKR